AnGes OTC Stock Top Insiders

AMGXF Stock  USD 0.46  0.00  0.00%   
AnGes employs about 131 people. The company is managed by 2 executives with a total tenure of roughly 306 years, averaging almost 153.0 years of service per executive, having 65.5 employees per reported executive. Examination of AnGes' management performance can provide insight into the company performance.
Naoya Sato  Insider
Director Director
Ei MD  Insider
Pres CEO
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnGes Inc. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest.

AnGes Management Team Effectiveness

The company has return on total asset (ROA) of (0.242) % which means that it has lost $0.242 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4262) %, meaning that it generated substantial loss on money invested by shareholders. AnGes' management efficiency ratios could be used to measure how well AnGes manages its routine affairs as well as how well it operates its assets and liabilities.

AnGes Workforce Comparison

AnGes Inc is rated fifth in number of employees category among related companies. The total workforce of Biotechnology industry is presently estimated at about 142,354. AnGes adds roughly 131 in number of employees claiming only tiny portion of stocks in Biotechnology industry.

AnGes Inc Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. AnGes Inc Price Series Summation is a cross summation of AnGes price series and its benchmark/peer.

AnGes Notable Stakeholders

An AnGes stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as AnGes often face trade-offs trying to please all of them. AnGes' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting AnGes' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Naoya SatoDirector DirectorProfile
Ei MDPres CEOProfile

About AnGes Management Performance

The success or failure of an entity such as AnGes Inc often depends on how effective the management is. AnGes management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of AnGes management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the AnGes management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan. Anges Mg is traded on OTC Exchange in the United States.
The data published in AnGes' official financial statements usually reflect AnGes' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AnGes Inc. For example, before you start analyzing numbers published by AnGes accountants, it's critical to develop an understanding of what AnGes' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of AnGes' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AnGes' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AnGes' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AnGes Inc. Please utilize our Beneish M Score to check the likelihood of AnGes' management manipulating its earnings.

AnGes Workforce Analysis

Traditionally, organizations such as AnGes use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare AnGes within its industry.

AnGes Manpower Efficiency

Return on AnGes Manpower

Revenue Per Employee489.7K
Revenue Per Executive32.1M
Net Loss Per Employee104.4M
Net Loss Per Executive6.8B
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AnGes Inc. Also, note that the market value of any otc stock could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.

Complementary Tools for AnGes OTC Stock analysis

When running AnGes' price analysis, check to measure AnGes' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AnGes is operating at the current time. Most of AnGes' value examination focuses on studying past and present price action to predict the probability of AnGes' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AnGes' price. Additionally, you may evaluate how the addition of AnGes to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Global Correlations
Find global opportunities by holding instruments from different markets
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Please note, there is a significant difference between AnGes' value and its price as these two are different measures arrived at by different means. Investors typically determine if AnGes is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AnGes' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.